NCT02764086 2026-04-13INTENSE: A Phase I/II Study of INhomogeneous Targeted Dose Escalation in Non-Small CEll Lung CancerCancer Trials IrelandPhase 1/2 Terminated6 enrolled
NCT04902040 2026-03-18Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted AntibodiesM.D. Anderson Cancer CenterPhase 1/2 Terminated19 enrolled 11 charts